165 related articles for article (PubMed ID: 35745664)
1. Mechanistic Analysis of Chemically Diverse Bromodomain-4 Inhibitors Using Balanced QSAR Analysis and Supported by X-ray Resolved Crystal Structures.
Zaki MEA; Al-Hussain SA; Al-Mutairi AA; Masand VH; Samad A; Jawarkar RD
Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745664
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic and Predictive QSAR Analysis of Diverse Molecules to Capture Salient and Hidden Pharmacophores for Anti-Thrombotic Activity.
Zaki MEA; Al-Hussain SA; Masand VH; Sabnani MK; Samad A
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361118
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophore Synergism in Diverse Scaffold Clinches in Aurora Kinase B.
Masand VH; Al-Hussain SA; Rathore MM; Thakur SD; Akasapu S; Samad A; Al-Mutairi AA; Zaki MEA
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498857
[TBL] [Abstract][Full Text] [Related]
4. Perceiving the Concealed and Unreported Pharmacophoric Features of the 5-Hydroxytryptamine Receptor Using Balanced QSAR Analysis.
Bukhari SNA; Elsherif MA; Junaid K; Ejaz H; Alam P; Samad A; Jawarkar RD; Masand VH
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890133
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Prominent and Concealed Inhibitory Features for Cytoplasmic Isoforms of Hsp90 Using QSAR Analysis.
Zaki MEA; Al-Hussain SA; Bukhari SNA; Masand VH; Rathore MM; Thakur SD; Patil VM
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337101
[TBL] [Abstract][Full Text] [Related]
6. Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches.
Bakal RL; Jawarkar RD; Manwar JV; Jaiswal MS; Ghosh A; Gandhi A; Zaki MEA; Al-Hussain S; Samad A; Masand VH; Mukerjee N; Nasir Abbas Bukhari S; Sharma P; Lewaa I
Saudi Pharm J; 2022 Jun; 30(6):693-710. PubMed ID: 35812153
[TBL] [Abstract][Full Text] [Related]
7. In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators.
Zaki MEA; Al-Hussain SA; Al-Mutairi AA; Samad A; Ghosh A; Chaudhari S; Khatale PN; Ajmire P; Jawarkar RD
Front Pharmacol; 2023; 14():1129997. PubMed ID: 37144217
[TBL] [Abstract][Full Text] [Related]
8. Structure features of peptide-type SARS-CoV main protease inhibitors: Quantitative structure activity relationship study.
Masand VH; Akasapu S; Gandhi A; Rastija V; Patil MK
Chemometr Intell Lab Syst; 2020 Nov; 206():104172. PubMed ID: 33518858
[TBL] [Abstract][Full Text] [Related]
9. QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA.
Jawarkar RD; Bakal RL; Mukherjee N; Ghosh A; Zaki MEA; Al-Hussain SA; Al-Mutairi AA; Samad A; Gandhi A; Masand VH
Molecules; 2022 Jul; 27(15):. PubMed ID: 35897936
[TBL] [Abstract][Full Text] [Related]
10. QSAR and Pharmacophore Modeling of Nitrogen Heterocycles as Potent Human
Zaki MEA; Al-Hussain SA; Masand VH; Akasapu S; Lewaa I
Molecules; 2021 Mar; 26(7):. PubMed ID: 33805223
[No Abstract] [Full Text] [Related]
11. Estrogen Receptor Alpha Binders for Hormone-Dependent Forms of Breast Cancer: e-QSAR and Molecular Docking Supported by X-ray Resolved Structures.
Masand VH; Al-Hussain SA; Alzahrani AY; Al-Mutairi AA; Hussien RA; Samad A; Zaki MEA
ACS Omega; 2024 Apr; 9(14):16759-16774. PubMed ID: 38617692
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic insights into mode of action of novel natural cathepsin L inhibitors.
Tyagi C; Grover S; Dhanjal J; Goyal S; Goyal M; Grover A
BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S10. PubMed ID: 24564425
[TBL] [Abstract][Full Text] [Related]
13. QSAR analysis of sodium glucose co-transporter 2 (SGLT2) inhibitors for anti-hyperglycaemic lead development.
Gandhi A; Masand V; Zaki MEA; Al-Hussain SA; Ghorbal AB; Chapolikar A
SAR QSAR Environ Res; 2021 Sep; 32(9):731-744. PubMed ID: 34494464
[TBL] [Abstract][Full Text] [Related]
14. A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.
Kumar V; De P; Ojha PK; Saha A; Roy K
Curr Top Med Chem; 2020; 20(18):1601-1627. PubMed ID: 32543359
[TBL] [Abstract][Full Text] [Related]
15. Use of the Monte Carlo Method for OECD Principles-Guided QSAR Modeling of SIRT1 Inhibitors.
Kumar A; Chauhan S
Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 28025857
[TBL] [Abstract][Full Text] [Related]
16. Extending the identification of structural features responsible for anti-SARS-CoV activity of peptide-type compounds using QSAR modelling.
Masand VH; Rastija V; Patil MK; Gandhi A; Chapolikar A
SAR QSAR Environ Res; 2020 Sep; 31(9):643-654. PubMed ID: 32847369
[TBL] [Abstract][Full Text] [Related]
17. Discovery of potent IRAK-4 inhibitors as potential anti-inflammatory and anticancer agents using structure-based exploration of IRAK-4 pharmacophoric space coupled with QSAR analyses.
Khanfar MA; Alqtaishat S
Comput Biol Chem; 2019 Apr; 79():147-154. PubMed ID: 30818109
[TBL] [Abstract][Full Text] [Related]
18. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
Aher RB; Roy K
Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
[TBL] [Abstract][Full Text] [Related]
19. Computational approaches for the design of novel dopamine D
Rathore A; Asati V; Mishra M; Das R; Kashaw V; Kashaw SK
In Silico Pharmacol; 2022; 10(1):7. PubMed ID: 35433192
[TBL] [Abstract][Full Text] [Related]
20. Exploring 2D-QSAR for prediction of beta-secretase 1 (BACE1) inhibitory activity against Alzheimer's disease.
Kumar V; Ojha PK; Saha A; Roy K
SAR QSAR Environ Res; 2020 Feb; 31(2):87-133. PubMed ID: 31865778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
